Showing results (1-10 of 74) with videos related to
Sort By:
Pageof 8
Health Policy (Amsterdam, Netherlands)|December 29, 2009
The US Orphan Drug Act: rare disease research stimulator or commercial opportunity?Olivier Wellman-Labadie, Youwen ZhouCutis|August 16, 2011
Refractory cutaneous Rosai-Dorfman disease responsive to cryotherapyRaina Fumerton, Nigel Ball, Youwen ZhouJournal of Cutaneous Medicine and Surgery|April 5, 2019
Existing and Emerging Therapies for Cutaneous T-Cell LymphomaVanessa Van-de-Velde, Youwen ZhouBiology|October 29, 2025
Unraveling Melasma: From Epidermal Pigmentation to Microenvironmental DysregulationFang Miao, Jing Wan, Youwen Zhou, et al.Journal of Cutaneous Medicine and Surgery|April 22, 2003
Mycophenolate mofetil (CellCept) for psoriasis: a two-center, prospective, open-label clinical trialYouwen Zhou, Don Rosenthal, Jan Dutz, et al.Journal of Cutaneous Medicine and Surgery|July 13, 2012
Potential role of neurogenic inflammatory factors in the pathogenesis of vitiligoRichard Yu, Yuanshen Huang, Xuejun Zhang, et al.Blood|December 31, 2014
Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphomaYuanshen Huang, Ming-Wan Su, Xiaoyan Jiang, et al.Oncology Letters|December 1, 2016
Prognostic significance of the expression of nuclear eukaryotic translation initiation factor 5A2 in human melanomaShahram Khosravi, Magdalena Martinka, Youwen Zhou, et al.Canadian Family Physician Medecin De Famille Canadien|April 29, 2005
Topical therapies for psoriasis: evidence-based reviewTarek Afifi, Gillian de Gannes, Changzheng Huang, et al.Cancer Metastasis Reviews|January 16, 2015
Immunotherapy of melanoma: present options and future promisesAnand Rotte, Madhuri Bhandaru, Youwen Zhou, et al.Pageof 8